Atara Biotherapeutics Inc (NASDAQ:ATRA)
| 0.6498 Delayed Data As of Dec 01 |  -0.0102 / -1.55%Today’s Change | 0.20 Today|||52-Week Range 5.64 | -80.19% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 48.0K | 383.0K | 956.0K | 3.8M | ||
| Operating Expenses | Gross Income | -48.0K | -383.0K | -956.0K | -3.8M | |
| General Expenses | 58.4M | 80.9M | 120.6M | 233.3M | ||
| Research And Development | 41.6M | 56.5M | 81.2M | 167.5M | ||
| Total Operating Expenses | 58.4M | 81.2M | 121.5M | 237.1M | ||
| Non-Operating Expenses | Operating Income | -58.4M | -81.2M | -121.5M | -237.1M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -57.2M | -79.0M | -119.5M | -230.7M | |
| Income Taxes | -9.0K | -10.0K | -14.0K | -44.0K | ||
| Net Income | -57.2M | -79.0M | -119.5M | -230.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 25.6M | 28.7M | 29.9M | 43.8M | |
| Shares To Calculate EPS Diluted | 25.6M | 28.7M | 29.9M | 43.8M | ||
| Earnings Per Share | EPS | -$2.24 | -$2.75 | -$4.00 | -$5.27 | |
| EPS Diluted | -$2.24 | -$2.75 | -$4.00 | -$5.27 | ||
